Terms: = Head and neck cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Clinical Outcome
13 results:
1. Adamantinoma-like Variant of Ewing Sarcoma in the Metatarsal Bone After Chemotherapy: Report of a Case Successfully Treated with Pedicled Osteocutaneous Fibular Transfer.
Marais YA; Saini AK; Ferreira N; Reddy K; Zühlke A; Rossouw N; Zaharie SD; Schubert PT
Int J Surg Pathol; 2021 Oct; 29(7):798-803. PubMed ID: 33703949
[TBL] [Abstract] [Full Text] [Related]
2. Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species.
Kitano Y; Baba Y; Nakagawa S; Miyake K; Iwatsuki M; Ishimoto T; Yamashita YI; Yoshida N; Watanabe M; Nakao M; Baba H
J Pathol; 2018 Mar; 244(3):346-357. PubMed ID: 29243822
[TBL] [Abstract] [Full Text] [Related]
3. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
[TBL] [Abstract] [Full Text] [Related]
4. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid cancer.
Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
[TBL] [Abstract] [Full Text] [Related]
5. PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.
Zhou X; Updegraff BL; Guo Y; Peyton M; Girard L; Larsen JE; Xie XJ; Zhou Y; Hwang TH; Xie Y; Rodriguez-Canales J; Villalobos P; Behrens C; Wistuba II; Minna JD; O'Donnell KA
Cancer Res; 2017 Jan; 77(1):187-197. PubMed ID: 27821484
[TBL] [Abstract] [Full Text] [Related]
6. Gene/protein expression of CAPN1/2-CAST system members is associated with erk1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.
Starska K; Forma E; Jóźwiak P; Lewy-Trenda I; Danilewicz M; Stasikowska-Kanicka O; Skóra M; Kolary K; Miazga J; Krześlak A; Bryś M
Tumour Biol; 2016 Oct; 37(10):13185-13203. PubMed ID: 27456359
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological Features of Low-Grade Thyroid-like Nasopharyngeal Papillary Adenocarcinoma.
Li M; Wei J; Yao X; Wang C
Cancer Res Treat; 2017 Jan; 49(1):213-218. PubMed ID: 27384157
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.
Psyrri A; Lee JW; Pectasides E; Vassilakopoulou M; Kosmidis EK; Burtness BA; Rimm DL; Wanebo HJ; Forastiere AA
Clin Cancer Res; 2014 Jun; 20(11):3023-32. PubMed ID: 24700741
[TBL] [Abstract] [Full Text] [Related]
9. Is biomarker research advancing in the era of personalized medicine for head and neck cancer?
Yokota T
Int J Clin Oncol; 2014 Apr; 19(2):211-9. PubMed ID: 24442754
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.
Lenarduzzi M; Hui AB; Alajez NM; Shi W; Williams J; Yue S; O'Sullivan B; Liu FF
PLoS One; 2013; 8(1):e53765. PubMed ID: 23335975
[TBL] [Abstract] [Full Text] [Related]
11. A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer.
Dumitru CA; Fechner MK; Hoffmann TK; Lang S; Brandau S
J Leukoc Biol; 2012 Apr; 91(4):591-8. PubMed ID: 22262799
[TBL] [Abstract] [Full Text] [Related]
12. Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.
Agulnik M; da Cunha Santos G; Hedley D; Nicklee T; Dos Reis PP; Ho J; Pond GR; Chen H; Chen S; Shyr Y; Winquist E; Soulieres D; Chen EX; Squire JA; Marrano P; Kamel-Reid S; Dancey J; Siu LL; Tsao MS
J Clin Oncol; 2007 Jun; 25(16):2184-90. PubMed ID: 17538163
[TBL] [Abstract] [Full Text] [Related]
13. P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines.
Shintani S; Zhang T; Aslam A; Sebastian K; Yoshimura T; Hamakawa H
Int J Oncol; 2006 Nov; 29(5):1111-7. PubMed ID: 17016641
[TBL] [Abstract] [Full Text] [Related]
